High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 130 participants.

Also called NCT03079115

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 130 participants (planned count) (from the registry)
Sponsor
Beijing Hospital (from the registry)
Registry
  • NCT NCT03079115
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03079115. Randomized; single masking; primary purpose treatment. Start 2017-08-21 (actual); primary completion 2020-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting
Acronym
PICAS
Condition
Carotid Artery Stenosis
Intervention (Drug)
High-dose Atorvastatin
Intervention (Drug)
Conventional-dose Atorvastatin
Lead sponsor
Beijing Hospital (class: other government)

Record details

Record id
cardio:ct-nct03079115
Content hash
391cee25d2f09597af712b5226eab084585c3ae06d7da3e22499bd3f1b1accd2